A-M-R
☆    

Egypt,
2014-10-12 13:14
(4265 d 09:20 ago)

Posting: # 13690
Views: 4,190
 

 Rosuvastatin BE study [Dissolution / BCS / IVIVC]

Results of comparative dissolution were at pH = 29 (failed), at pH 4.5 = 58 and at pH 6.8 = 57 so advice me if I can start clinical part of BE study based on above results of comparative dissolution and appropriate design of study to decrease difference.
very thanks
Amr hussein


Edit: Category changed. [Helmut]
UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
115 visitors (0 registered, 115 guests [including 14 identified bots]).
Forum time: 22:35 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5